Rethinking platelet transfusion practices
- PMID: 33983425
- PMCID: PMC9635521
- DOI: 10.1182/blood.2021011269
Rethinking platelet transfusion practices
Conflict of interest statement
Conflict-of-interest disclosure: D.V.D. is a member of the scientific advisory board of Macopharma and has received research support from TerumoBCT, Hemanext, and Macopharma.
Comment on
-
Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage.Blood. 2021 May 13;137(19):2699-2703. doi: 10.1182/blood.2020008381. Blood. 2021. PMID: 33649761 Free PMC article.
References
-
- Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al; PATCH Investigators . Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387(10038):2605-2613. - PubMed
-
- Baharoglu MI, Al-Shahi Salman R, Cordonnier C, et al. PATCH trial: explanatory analyses. Blood. 2020;135(16):1406-1409. - PubMed
-
- Blumberg N, Heal JM, Hicks GL Jr., Risher WH. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion. 2001;41(6):790-793. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources